Home Tags Yancopoulos

Tag: Yancopoulos

Regeneron dermatitis drug approved for European market

The antibody drug will be marketed as Dupixent and available to adults with moderate to severe atopic dermatitis .

FDA approves Regeneron drug Kevzara for rheumatoid arthritis

The new human antibody drug will be used to treat a chronic inflammatory disease that affects about 1.3 million Americans.

FDA approves new Regeneron drug treating severe eczema

Dupixent will go on the U.S. market this week as the first antibody medicine for uncontrolled itching and rashes in adults with atopic dermatitis.

Regeneron grows and celebrates success

The state’s largest biotechnology employer plans to add 400 jobs at its expanded headquarters in Westchester.